What Makes Verona Pharma PLC American Depositary Share (VRNA) a Strong Momentum Stock: Buy Now?

Core Viewpoint - Momentum investing focuses on following a stock's recent price trends, with the aim of buying high and selling higher, capitalizing on established price movements [1] Company Overview: Verona Pharma PLC (VRNA) - VRNA currently holds a Momentum Style Score of B, indicating a positive momentum outlook [2] - The stock has a Zacks Rank of 1 (Strong Buy), suggesting strong potential for outperformance in the market [3] Performance Metrics - Over the past week, VRNA shares have increased by 14.53%, significantly outperforming the Zacks Medical - Biomedical and Genetics industry, which rose by 2.16% [5] - In a longer timeframe, VRNA shares have gained 74.25% over the past quarter and 386.84% over the last year, while the S&P 500 has only increased by 16.27% and 12.91%, respectively [6] Trading Volume - The average 20-day trading volume for VRNA is 6,108,280 shares, indicating strong interest and a bullish sentiment in the stock [7] Earnings Outlook - In the last two months, three earnings estimates for VRNA have been revised upwards, with the consensus estimate increasing from $0.16 to $0.22 [9] - For the next fiscal year, two estimates have also moved higher, with no downward revisions noted [9] Conclusion - Given the strong performance metrics and positive earnings outlook, VRNA is positioned as a promising investment opportunity with a Momentum Score of B and a Zacks Rank of 1 (Strong Buy) [11]